BackCRH Medical Overview

CRH Medical Current Cash

Latest current cash for CRHM: $3.9M.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$3.92M
↓ 40.33% YoYΔ $-2.65M vs prior year quarter

Peer average

Loading

CRH Medical Current Cash History

Loading

CRH Medical vs. peers: Current Cash Comparison

Loading

CRH Medical Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

CRH Medical (CRHM) FAQ

As of the most recent data (December 2020), CRHM shows a current cash of $3.9M. That compares with $6.6M in the prior-year period — down 40.3% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, CRHM's current cash is now $3.9M (was $6.6M) — a 40.3% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether CRH Medical is outperforming or lagging.

Tracking CRHM's current cash over time shows whether CRH Medical is scaling, shrinking, or reshaping that part of the business. The current reading is $3.9M That compares with $6.6M in the prior-year period — down 40.3% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current cash page, Stockcircle has CRH Medical's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current cash (currently $3.9M) with ownership activity and broader fundamentals.

CRH Medical's current cash is $3.9M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.